These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7337456)

  • 21. Effects of psychotropic drugs on intelligence test performance of institutionalized mentally retarded adults.
    Breuning SE; Davidson NA
    Am J Ment Defic; 1981 May; 85(6):575-9. PubMed ID: 6791499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics.
    Addonizio G
    J Clin Psychopharmacol; 1985 Oct; 5(5):296-8. PubMed ID: 4044883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observations on the acoustic reflex threshold in institutionalized retarded adults taking mellaril and/or thorazine.
    Niswander PS; Helfner-Mitchell F
    Ear Hear; 1988 Feb; 9(1):9-14. PubMed ID: 3342946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
    Correll CU; Leucht S; Kane JM
    Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diazepam in the treatment of tardive dyskinesia. Preliminary observations.
    Singh MM
    Int Pharmacopsychiatry; 1976; 11(4):232-4. PubMed ID: 1010710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical and typical neuroleptics and tardive dyskinesia.
    Borison RL; Shah C; White TH; Diamond BI
    Psychopharmacol Bull; 1987; 23(1):218-20. PubMed ID: 3602323
    [No Abstract]   [Full Text] [Related]  

  • 27. Tardive dyskinesia: are first signs reversible?
    Quitkin F; Rifkin A; Gochfeld L; Klein DF
    Am J Psychiatry; 1977 Jan; 134(1):84-7. PubMed ID: 12666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
    Guo GY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
    [No Abstract]   [Full Text] [Related]  

  • 29. Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
    Paulson GW; Rizvi CA; Crane GE
    Clin Pediatr (Phila); 1975 Oct; 14(10):953-5. PubMed ID: 1100296
    [No Abstract]   [Full Text] [Related]  

  • 30. Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment.
    Aman MG; Singh NN
    J Ment Defic Res; 1985 Jun; 29 ( Pt 2)():187-95. PubMed ID: 2863380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyskinesia in the mentally handicapped.
    Kohen D; Mathew G
    Br J Psychiatry; 1990 Oct; 157():621. PubMed ID: 2131150
    [No Abstract]   [Full Text] [Related]  

  • 32. The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions [proceedings].
    Guy W; Petrie W; Cleary P
    Psychopharmacol Bull; 1978 Apr; 14(2):22-4. PubMed ID: 349600
    [No Abstract]   [Full Text] [Related]  

  • 33. Tourette-like syndrome after long-term neuroleptic drug treatment.
    Mueller J; Aminoff MJ
    Br J Psychiatry; 1982 Aug; 141():191-3. PubMed ID: 6956422
    [No Abstract]   [Full Text] [Related]  

  • 34. Dyskinesia in mentally handicapped women: relationship to level of handicap, age and neuroleptic exposure.
    Farren CK; Dinan TG
    Acta Psychiatr Scand; 1994 Sep; 90(3):210-3. PubMed ID: 7810345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients.
    Malt UF; Nystad R; Bache T; Noren O; Sjaastad M; Solberg KO; Tønseth S; Zachariassen P; Maehlum E
    Br J Psychiatry; 1995 Mar; 166(3):374-7. PubMed ID: 7788130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of intermittent drug therapy on stereotypy and collateral behaviors of mentally retarded persons.
    Millichamp CJ; Singh NN
    Res Dev Disabil; 1987; 8(2):213-27. PubMed ID: 2890189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
    Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV
    Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study.
    Cohen-Mansfield J; Lipson S; Werner P; Billig N; Taylor L; Woosley R
    Arch Intern Med; 1999 Aug 9-23; 159(15):1733-40. PubMed ID: 10448776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.